biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by cornpieon May 28, 2018 2:32pm

113 Views

Post# 28089735

RE:RE:RE:RE:RE:RE:Nanoparticles carrying two drugs can cross the blood-brain b

Good answer BearDownAZ. I almost can't tell which end digital -sir holler has his tail pinned on any more. I guess which ever way his handlers point him will be the direction that he farts. Might be time to change his alias again so his post might have a little more credibility until we figure out who he is again, which shouldn't take too long.

Bullboard Posts

Abcourt Mines launches Flordin property drill campaign